Page 8 - Seg Way News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Seg way. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Seg Way Today - Breaking & Trending Today

London Stock Exchange Group platforms suffer brief outages

MUMBAI/SINGAPORE (Reuters) -Various London Stock Exchange Group (LSEG) news and currency trading platforms around the world suffered brief outages as European markets opened on Thursday. LSEG's Eikon and Workspace market data platforms and its interbank foreign exchange matching systems FXT and FXall all stopped functioning, traders in India and Singapore said. An LSEG spokesperson did not respond immediately to an emailed request for comment. ....

City Of , United Kingdom , Kim Coghill , Alun Johnadditional , Nimesh Vora , David Goodman , Vidya Ranganathan , Jacqueline Wong , Thomson Reuters , London Stock Exchange Group , London Stock Exchange , Various London Stock Exchange Group , Reuters News , Urrency Trading Platforms , Interbank Foreign Exchange , Foreign Exchange ,

LSEG enhances parental leave offering

Global employees can now take advantage of 26 weeks of paid parental leave ....

Parental Leave , Employee Benefits ,

Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost

U.S.-based Eli Lilly and Denmark's Novo Nordisk have struck gold with their weight-loss drugs, sending their shares to stratospheric levels and putting them on par with some high-growth tech stocks. Retail and institutional investors alike have flocked to the two stocks in the past year, as they bet on explosive demand for the companies' obesity drugs, called GLP-1 agonists, in a market that some analysts expect could breach $100 billion. Lilly shares trade 56.17 times the earnings estimates for the next 12 months, while Novo has a price-to-earnings (PE) multiple of 35.84, according to LSEG data. ....

New York , United States , Dan Coatsworth , Eli Lilly , Jason Benowitz , Medha Singh , Manas Mishra , Sweta Singh , Novo Nordisk , Research Sel Hardy , Wall Street , Sel Hardy , Bart Hogan , Anild Silva , Eli Lilly , Growth Stocks , Obesity Drugs ,